Table 2.

Efficient transduction of in vivo repopulating HSCs with cyclin D2–containing vector



1° recipients

2° recipients

% Donor (CD45.2) reconstitution (SD)
% GFP+ donor cells (SD)
% Donor (CD45.2) reconstitution (SD)
% GFP+ donor cells (SD)
Experiment 1     
    Control vector   72.7 (5.2)   48.5 (7.4)   60.7 (21.0)   42.5 (42.8)  
    Cyclin D2 vector   76.2 (3.3)   33.7 (10.6)   81.9 (10.6)   36.8 (33.3)  
Experiment 2     
    Control vector   58.4 (12.1)   99.4 (0.9)   34.6 (43.3)   99.1 (1.2)  
    Cyclin D2 vector
 
43.7 (15.4)
 
97.3 (2.9)
 
23.0 (18.9)
 
98.1 (3.3)
 


1° recipients

2° recipients

% Donor (CD45.2) reconstitution (SD)
% GFP+ donor cells (SD)
% Donor (CD45.2) reconstitution (SD)
% GFP+ donor cells (SD)
Experiment 1     
    Control vector   72.7 (5.2)   48.5 (7.4)   60.7 (21.0)   42.5 (42.8)  
    Cyclin D2 vector   76.2 (3.3)   33.7 (10.6)   81.9 (10.6)   36.8 (33.3)  
Experiment 2     
    Control vector   58.4 (12.1)   99.4 (0.9)   34.6 (43.3)   99.1 (1.2)  
    Cyclin D2 vector
 
43.7 (15.4)
 
97.3 (2.9)
 
23.0 (18.9)
 
98.1 (3.3)
 

Lethally irradiated mice (1° recipients, CD45.1) received transplants with 5000 (experiment 1) or 1250 (experiment 2) LSK (CD45.2) cells transduced with control- or cyclin D2–containing vectors ('Materials and methods'), and 200 000 (experiment 1) or 100 000 (experiment 2) whole BM (CD45.1) cells. Four months later, half a femur equivalent BM cells from 1° recipients were serially transplanted into 2° (CD45.1) recipients. Reconstitution was analyzed in PB 4 months (1° recipients) and 3 months (2° recipients) after transplantation. As shown for 1° recipients in Table 1, control- and cyclin D2–transduced (GFP+) progenitors showed comparable contributions to B (B220), T (CD3), and myeloid (CD11b/Gr1) lineages also in 2° recipients. Data are mean values (SD) from 4 to 7 mice in each group and experiment.

Close Modal

or Create an Account

Close Modal
Close Modal